Heron Therapeutics
HRTX
#8256
Rank
ยฃ0.18 B
Marketcap
ยฃ0.98
Share price
0.00%
Change (1 day)
-22.67%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2025 (TTM): ยฃ0.11 Billion

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.11 Billion. In 2024 the company made a revenue of ยฃ0.11 Billion an increase over the revenue in the year 2023 that were of ยฃ99.72 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.11 B2.74%
2024 ยฃ0.11 B15.3%
2023 ยฃ99.72 M12.05%
2022 ยฃ88.99 M39.13%
2021 ยฃ63.96 M-1.63%
2020 ยฃ65.02 M-41.58%
2019 ยฃ0.11 B82.38%
2018 ยฃ61.03 M168.11%
2017 ยฃ22.76 M2096.23%
2016 ยฃ1.03 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 ยฃ0.41 M-50.68%
2010 ยฃ0.84 M8.15%
2009 ยฃ0.77 M208.67%
2008 ยฃ0.25 M
2005 ยฃ3.12 M11.06%
2004 ยฃ2.81 M3.84%
2003 ยฃ2.71 M-21.4%
2002 ยฃ3.44 M13.98%
2001 ยฃ3.02 M34.18%
2000 ยฃ2.25 M-82.78%
1999 ยฃ13.09 M9.98%
1998 ยฃ11.9 M7.48%
1997 ยฃ11.07 M0.91%
1996 ยฃ10.97 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alkermes
ALKS
ยฃ1.14 B 880.89%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Pacira Biosciences
PCRX
ยฃ0.53 B 362.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
ยฃ46.95 M-59.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.18 B 61.98%๐Ÿ‡บ๐Ÿ‡ธ USA
SurModics
SRDX
ยฃ90.61 M-22.11%๐Ÿ‡บ๐Ÿ‡ธ USA